[ExI] thiel goes south

[Adrian Tymes]

On Sep 1, 2017 7:55 AM, "spike" <spike66 at att.net> wrote:

Thiel’s argument: the volunteers who took the vaccines already had herpes
and did not have access to treatment.  So the worst that could happen is
nothing.

Not so.  The treatment could kill the subjects, or turn their genitals
(urethras included) into bloody, painful,
in-hospitals-for-the-rest-of-their-short-lives messes, or worse.  The
clinical trials are intended to limit that and other problems, make certain
they do not afflict a lot of people - and make sure the treatment works.

 What happens if Thiel discovers this vaccine works, but declines to do FDA
testing?  Then do we have a drug which can be used overseas but is illegal
in the USA?

Yes.  But also one that seems proven, so getting the money for FDA trials
would be easier.

Would it then be kinda like cocaine except that it actually prevents
disease instead of getting the user stoned?

Medicine of any form is not "kinda like" cocaine, despite any superficial
similarity of legal status.  For one, not all countries outside the US have
the same laws.  For another, mere possession of medicine in the US is not a
crime, even if it is not yet FDA approved.

Imagine if other investors recognize that there are markets for drugs
outside the USA and that the approval process here has gone from difficult
to absurd.  Then they follow suit and create new classes of drugs and
therapies using populations willing to take chance.

You think the big pharma companies are not already well aware of this, and
using it where it makes sense?  For all the expense of FDA trials, they are
kind of the gold standard: if even the FDA signs off on a new drug, you can
usually sell it throughout most of the Western world, with confidence there
will be no hidden side effect to ruin all the money you have sunk into
setting up huge factories for it.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.extropy.org/pipermail/extropy-chat/attachments/20170901/955929f8/attachment.html>